Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: Evidence for improved models

Journal of Urology

Volumn 191, Issue 1, 2014, Pages 261-269

  Mengual, Lourdes ^a   Ribal, María José ^a   Lozano, Juan José ^a   Ingelmo Torres, Mercedes ^a   Burset, Moisés ^a   Fernández, Pedro Luís ^a   Alcaraz, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

biological markers; carcinoma; gene expression; urinary bladder; urothelium

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER PROGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA MICROARRAY; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MICTURITION; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINALYSIS; VALIDATION STUDY; CANCER DIAGNOSIS; CYSTOSCOPY; CYTOLOGY;

BIOLOGICAL MARKERS; CARCINOMA; CARCINOMA IN SITU; CIS; CQ; CYCLE QUANTIFICATION; GENE EXPRESSION; HG; HIGH GRADE; LEAVE-ONE-OUT CROSS VALIDATION; LG; LOOCV; LOW GRADE; MIBC; MUSCLE INVASIVE BLADDER CANCER; NMIBC; NONMIBC; PCR; POLYMERASE CHAIN REACTION; SENSITIVITY; SN; SP; SPECIFICITY; UCC; URINARY BLADDER; UROTHELIAL CELL CARCINOMA; UROTHELIUM;

HUMANS; PROGNOSIS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84890040816     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.06.083     Document Type: Article

References (30)

1. H.B. Grossman, M. Soloway, and E. Messing Surveillance for recurrent bladder cancer using a point-of-care proteomic assay JAMA 295 2006 299
2. A.S. Glas, D. Roos, and M. Deutekom Tumor markers in the diagnosis of primary bladder cancer. A systematic review J Urol 169 2003 1975
3. V.B. Lokeshwar, T. Habuchi, and H.B. Grossman Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers Urology 66 2005 35
4. I. Proctor, K. Stoeber, and G.H. Williams Biomarkers in bladder cancer Histopathology 57 2010 1
5. L. Dyrskjot, K. Zieger, and F.X. Real Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study Clin Cancer Res 13 2007 3545
6. M. Sanchez-Carbayo, N.D. Socci, and J. Lozano Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays J Clin Oncol 24 2006 778
7. E. Blaveri, J.P. Simko, and J.E. Korkola Bladder cancer outcome and subtype classification by gene expression Clin Cancer Res 11 2005 4044
8. R. Wang, D.S. Morris, and S.A. Tomlins Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancer Cancer Res 69 2009 3810
9. L. Mengual, M. Burset, and E. Ars DNA Microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers J Urol 182 2009 741
10. A. Holyoake, P. O'Sullivan, and R. Pollock Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder Clin Cancer Res 14 2008 742
11. X.Y. Xie, X. Yang, and J.H. Zhang Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR Ann Clin Biochem 44 2007 523
12. L. Mengual, M. Burset, and M.J. Ribal Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma Clin Cancer Res 16 2010 2624
13. Lopez-Beltran A, Sauter G, Gasser T, et al. Tumours of the urinary system. In: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumours. Edited by JN Eble, G Sauter, JI Epstein et al. Lyon: IARC Press 2004; chapt 2, p 89.
14. L.H. Sobin, and C.H. Wittekind TNM Classification of Malignant Tumours. International Union Against Cancer 2002 John Wiley & Sons New York
15. L. Mengual, M. Burset, and M. Marin-Aguilera Multiplex preamplification of specific cDNA targets prior to gene expression analysis by TaqMan Arrays BMC Res Notes 1 2008 21
16. Hastie TJ and Pregibon D: Generalized linear models. In: Statistical Models in S. Edited by JM Chambers and TJ Hastie. Independence, Kentucky: Wadsworth & Brooks Cole 1992.
17. X. Robin, N. Turck, and A. Hainard pROC: an open-source package for R and S+ to analyze and compare ROC curves BMC Bioinformatics 12 2011 77
18. J.J. Goeman, S.A. van de Geer, and F. de Kort A global test for groups of genes: testing association with a clinical outcome Bioinformatics 20 2004 93
19. E.B. Avritscher, C.D. Cooksley, and H.B. Grossman Clinical model of lifetime cost of treating bladder cancer and associated complications Urology 68 2006 549
20. A.A. Van Tilborg, C.H. Bangma, and E.C. Zwarthoff Bladder cancer biomarkers and their role in surveillance and screening Int J Urol 16 2009 23
21. L. Cheng, S. Zhang, and G.T. MacLennan Bladder cancer: translating molecular genetic insights into clinical practice Hum Pathol 42 2011 455
22. P. O'Sullivan, K. Sharples, and M. Dalphin A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria J Urol 188 2012 741
23. C.J. Rosser, L. Liu, and Y. Sun Bladder cancer-associated gene expression signatures identified by profiling of exfoliated urothelia Cancer Epidemiol Biomarkers Prev 18 2009 444
24. V. Urquidi, S. Goodison, and Y. Cai A candidate molecular biomarker panel for the detection of bladder cancer Cancer Epidemiol Biomarkers Prev 21 2012 2149
25. M.S. Soloway, M. Sofer, and A. Vaidya Contemporary management of stage T1 transitional cell carcinoma of the bladder J Urol 167 2002 1573
26. A. Arcaro Targeting the insulin-like growth factor-1 receptor in human cancer Front Pharmacol 4 2013 30
27. G. Pignot, A. Vieillefond, and S. Vacher Hedgehog pathway activation in human transitional cell carcinoma of the bladder Br J Cancer 106 2012 1177
28. L. Marcar, N.J. Maclaine, and T.R. Hupp Mage-A cancer/testis antigens inhibit p53 function by blocking its interaction with chromatin Cancer Res 70 2010 10362
29. L. Dyrskjot, K. Zieger, and L.T. Kissow Expression of MAGE-A3, NY-ESO-1 LAGE-1 and PRAME in urothelial carcinoma. Br J Cancer 107 2012 116
30. P.J. Goebell, and M.A. Knowles Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium Urol Oncol 28 2010 409